The IDSA guideline recommendations are primarily based on low-quality evidence derived from non-randomized studies or expert opinion. These findings highlight the limitations of current clinical infectious diseases research that can provide high-quality evidence. There is an urgent need to support high-quality research to strengthen the evidence available for the formulation of guidelines. Quality and Strength of Evidence of the Infectious Diseases Society of America Clinical Practice Guidelines Abdur Rahman Khan,Sobia Khan, Valerie Zimmerman, Larry M. Baddour, and Imad M. Tleyjeh Division of Infectious Diseases, Department of Medicine, and Research Centre, King Fahd Medical City, Riyadh, Saudi Arabia; and Division of Infectious Diseases, Department of Medicine, and Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota Infect Drug Resist. 2011; 4: 1–9. Published online Jan 7, 2011. doi: 10.2147/IDR.S15653 PMCID: PMC3108755 Full paper online: cid.oxfordjournals.org/content/51/10/1147.full.pdf
Posted on: Sat, 03 May 2014 23:25:02 +0000
Trending Topics
Recently Viewed Topics
© 2015